BioPharma Dive October 27, 2022
The facility is designed to address what its founders call a “bottleneck” by helping researchers turn their ideas into therapeutics.
A new hub for gene and cell therapy opened Thursday outside Boston, with the aim of giving lab space and manufacturing assistance to researchers developing the complex medicines.
The facility, known as Landmark Bio and based in Watertown, Mass., was born out of an unusual and broad alliance between Harvard University, MIT, and a variety of hospitals and biotech companies in the region. It was first announced in 2019, initially called the “Center for Advanced Biological Innovation and Manufacturing” and meant to address what its founders call a “bottleneck” in turning gene and cell therapy research into drug prospects....
Today's Sponsors
Today's Sponsor